A detailed history of Future Fund LLC transactions in Argenx Se stock. As of the latest transaction made, Future Fund LLC holds 736 shares of ARGX stock, worth $425,481. This represents 0.57% of its overall portfolio holdings.

Number of Shares
736
Holding current value
$425,481
% of portfolio
0.57%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$571.0 - $671.75 $420,256 - $494,408
736 New
736 $435,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Future Fund LLC Portfolio

Follow Future Fund LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Future Fund LLC, based on Form 13F filings with the SEC.

News

Stay updated on Future Fund LLC with notifications on news.